Evidence map›Paper›PMID 19605688›Full record

ArticleGenes & development2009

Pre-TCR signaling inactivates Notch1 transcription by antagonizing E2A.

Yumi Yashiro-Ohtani, Yiping He, Takuya Ohtani, Mary E Jones, Olga Shestova, Lanwei Xu, Terry C Fang, Mark Y Chiang, Andrew M Intlekofer, Stephen C Blacklow and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 191 citations in OpenAlex.

  1. Trial
  2. Article
  3. Tumor-Associated Glycan Exploits Adenosine Receptor 2A Signaling to Facilitate Immune Evasion.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Food for thought: Nutrient metabolism controlling early T cell development.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  8. T Cell Development: From T-Lineage Specification to Intrathymic Maturation.Advances in experimental medicine and biology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Transcriptional network dynamics in early T cell development.The Journal of experimental medicine · 2024
    Review
  13. Article
  14. CaInternational journal of molecular sciences · 2023
    Article
  15. Notch Partners in the Long Journey of T-ALL Pathogenesis.International journal of molecular sciences · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Yumi Yashiro-OhtaniDepartment of Pathology and Laboratory Medicine, Abramson Family Cancer Research Institute, Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Yiping He
Takuya Ohtani
Mary E Jones
Olga Shestova
Lanwei Xu
Terry C Fang
Mark Y Chiang
Andrew M Intlekofer
Stephen C Blacklow
Yuan Zhuang
Warren S Pear
University of Pennsylvania · USDuke Medical Center · USBrigham and Women's Hospital · US

Funding

Protein CoreP01CA119070 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ASTER, JON C. · 2006 to 2016
$10.3M
Structure and Function in Notch SignalingR01CA092433 · NCI · HARVARD MEDICAL SCHOOL · PI BLACKLOW, STEPHEN C. · 2002 to 2016
$5.0M
NCI NIH HHS P01 CA119070NCI NIH HHS R01 CA092433
6 · The paper itself

Abstract

Precise control of the timing and magnitude of Notch signaling is essential for the normal development of many tissues, but the feedback loops that regulate Notch are poorly understood. Developing T cells provide an excellent context to address this issue. Notch1 signals initiate T-cell development and increase in intensity during maturation of early T-cell progenitors (ETP) to the DN3 stage. As DN3 cells undergo beta-selection, during which cells expressing functionally rearranged TCRbeta proliferate and differentiate into CD4(+)CD8(+) progeny, Notch1 signaling is abruptly down-regulated. In this report, we investigate the mechanisms that control Notch1 expression during thymopoiesis. We show that Notch1 and E2A directly regulate Notch1 transcription in pre-beta-selected thymocytes. Following successful beta-selection, pre-TCR signaling rapidly inhibits Notch1 transcription via signals that up-regulate Id3, an E2A inhibitor. Consistent with a regulatory role for Id3 in Notch1 down-regulation, post-beta-selected Id3-deficient thymocytes maintain Notch1 transcription, whereas enforced Id3 expression decreases Notch1 expression and abrogates Notch1-dependent T-cell survival. These data provide new insights into Notch1 regulation in T-cell progenitors and reveal a direct link between pre-TCR signaling and Notch1 expression during thymocyte development. Our findings also suggest new strategies for inhibiting Notch1 signaling in pathologic conditions.

Indexed as

Gene Expression RegulationSignal TransductionAnimalsBasic Helix-Loop-Helix ProteinsCell LineDown-RegulationGenes, T-Cell Receptor betaHomeodomain ProteinsInhibitor of Differentiation ProteinsMiceMice, Inbred C57BLPromoter Regions, GeneticProtein BindingReceptor, Notch1RNA, MessengerBasic Helix-Loop-Helix ProteinsBhlhe40 protein, mouseHomeodomain ProteinsIdb3 protein, mouseInhibitor of Differentiation ProteinsNotch1 protein, mouseReceptor, Notch1RNA, MessengerTcf3 protein, mouse

Identifiers

PMID19605688
PMCPMC2714710
OpenAlexW2131795672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.